| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33029620_HAS_TOPIC_C0014410> <https://research.tib.eu/covid-19/entity/33029620_HAS_TOPIC_C0034019> <https://research.tib.eu/covid-19/entity/33029620_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33029620_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/33029620_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33029620_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33029620_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.\', \'Division of Infectious Diseases, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\', \'Infection Control Department, Brigham and Women\'s Hospital, Boston, Massachusetts, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Baker_Meghan> <https://research.tib.eu/covid-19/entity/Kanjilal_Sanjat> <https://research.tib.eu/covid-19/entity/Klompas_Michael> <https://research.tib.eu/covid-19/entity/Rhee_Chanu>
?:doi	10.1093/cid/ciaa1249
?:doi	<https://research.tib.eu/covid-19/entity/10.1093/cid/ciaa1249>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_N.I.H.%2C_Extramural> <https://research.tib.eu/covid-19/entity/Research_Support%2C_U.S._Gov%27t%2C_Non-P.H.S.> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33029620>
?:pmid	<https://research.tib.eu/covid-19/entity/33029620>
?:pmid	33029620
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0231218_PROCESS_OF_C0030705>
?:title	Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33029620>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33029620>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all